$ISCO
International Stem Cell CORP

2019 Q3 Form 10-Q Financial Statement

#000156459019033042 Filed on August 27, 2019

View on sec.gov

Income Statement

Concept 2019 Q3 2019 Q2 2018 Q4
Revenue $2.096M $2.321M $2.223M
YoY Change -34.4% -23.6% 20.82%
Cost Of Revenue $799.0K $857.0K $834.0K
YoY Change -39.24% -21.74% 34.52%
Gross Profit $1.297M $1.464M $1.389M
YoY Change -31.01% -24.65% 13.85%
Gross Profit Margin 61.88% 63.08% 62.48%
Selling, General & Admin $2.005M $2.137M $2.100M
YoY Change 4.05% 15.02% -16.0%
% of Gross Profit 154.59% 145.97% 151.19%
Research & Development $115.0K $268.0K $517.0K
YoY Change -81.33% -40.71% -13.83%
% of Gross Profit 8.87% 18.31% 37.22%
Depreciation & Amortization $40.00K $66.00K $93.00K
YoY Change -11.11% 50.0% 16.25%
% of Gross Profit 3.08% 4.51% 6.7%
Operating Expenses $2.110M $2.405M $2.649M
YoY Change -17.03% 4.11% -15.9%
Operating Profit -$813.0K -$941.0K -$1.260M
YoY Change 22.62% 156.4% -34.72%
Interest Expense $816.0K $20.00K $254.0K
YoY Change 4700.0% 185.71% -52.96%
% of Operating Profit
Other Income/Expense, Net $816.0K $293.0K -$22.00K
YoY Change 1797.67% -1185.19%
Pretax Income $3.000K -$648.0K -$1.028M
YoY Change -97.52% 66.15% -26.04%
Income Tax $0.00
% Of Pretax Income
Net Earnings $3.000K -$648.0K -$1.028M
YoY Change -97.52% 64.47% -26.04%
Net Earnings / Revenue 0.14% -27.92% -46.24%
Basic Earnings Per Share -$0.09
Diluted Earnings Per Share $397.60 -$0.09 -$150.0K
COMMON SHARES
Basic Shares Outstanding 7.533M 7.533M 6.771M
Diluted Shares Outstanding 7.533M

Balance Sheet

Concept 2019 Q3 2019 Q2 2018 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $463.0K $600.0K $1.080M
YoY Change -22.18% 25.0% 260.0%
Cash & Equivalents $463.0K $600.0K $1.075M
Short-Term Investments
Other Short-Term Assets $307.0K $440.0K $540.0K
YoY Change -30.23% -22.81% -30.77%
Inventory $1.409M $1.317M $1.501M
Prepaid Expenses
Receivables $1.080M $976.0K $651.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $3.259M $3.328M $3.770M
YoY Change -2.07% -23.32% 32.05%
LONG-TERM ASSETS
Property, Plant & Equipment $1.475M $697.0K $469.0K
YoY Change 325.07% 83.42% 46.11%
Goodwill
YoY Change
Intangibles $2.790M $2.674M
YoY Change -8.49%
Long-Term Investments
YoY Change
Other Assets $835.0K $880.0K $880.0K
YoY Change -4.79% 12.82% 14.29%
Total Long-Term Assets $5.001M $5.213M $4.026M
YoY Change -4.07% 27.77% 0.42%
TOTAL ASSETS
Total Short-Term Assets $3.259M $3.328M $3.770M
Total Long-Term Assets $5.001M $5.213M $4.026M
Total Assets $8.260M $8.541M $7.796M
YoY Change -3.29% 1.44% 13.58%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $722.0K $731.0K $458.0K
YoY Change -1.23% -59.84% -44.82%
Accrued Expenses $887.0K $548.0K $579.0K
YoY Change 9.1% -33.17% -4.61%
Deferred Revenue
YoY Change
Short-Term Debt $1.848M $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.707M $4.458M $5.077M
YoY Change -16.85% -34.15% 5.77%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $929.0K $970.0K $180.0K
YoY Change -4.62%
Total Long-Term Liabilities $929.0K $970.0K $180.0K
YoY Change -4.62%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.707M $4.458M $5.077M
Total Long-Term Liabilities $929.0K $970.0K $180.0K
Total Liabilities $4.636M $5.432M $5.259M
YoY Change -14.65% -19.76% 9.56%
SHAREHOLDERS EQUITY
Retained Earnings -$103.7M -$106.7M
YoY Change 2.04%
Common Stock $8.000K $7.000K
YoY Change 16.67%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$676.0K -$1.191M $2.537M
YoY Change
Total Liabilities & Shareholders Equity $8.260M $8.540M $7.796M
YoY Change -3.29% 1.43% 13.58%

Cashflow Statement

Concept 2019 Q3 2019 Q2 2018 Q4
OPERATING ACTIVITIES
Net Income $3.000K -$648.0K -$1.028M
YoY Change -97.52% 64.47% -26.04%
Depreciation, Depletion And Amortization $40.00K $66.00K $93.00K
YoY Change -11.11% 50.0% 16.25%
Cash From Operating Activities -$27.00K -$648.0K $34.00K
YoY Change -95.14% 27.06% -106.94%
INVESTING ACTIVITIES
Capital Expenditures -$105.0K -$172.0K -$132.0K
YoY Change -18.6% -14.0% -37.14%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$105.0K -$172.0K -$132.0K
YoY Change -18.6% -14.0% -37.14%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 800.0K 12.00K
YoY Change -100.0% 8.11% -97.6%
NET CHANGE
Cash From Operating Activities -27.00K -648.0K 34.00K
Cash From Investing Activities -105.0K -172.0K -132.0K
Cash From Financing Activities 0.000 800.0K 12.00K
Net Change In Cash -132.0K -20.00K -86.00K
YoY Change -119.21% -166.67% -57.0%
FREE CASH FLOW
Cash From Operating Activities -$27.00K -$648.0K $34.00K
Capital Expenditures -$105.0K -$172.0K -$132.0K
Free Cash Flow $78.00K -$476.0K $166.0K
YoY Change -118.27% 53.55% -159.29%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
204494098
dei Entity Address Address Line1
EntityAddressAddressLine1
5950 Priestly Drive
dei Entity Address City Or Town
EntityAddressCityOrTown
Carlsbad
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92008
dei City Area Code
CityAreaCode
760
dei Local Phone Number
LocalPhoneNumber
940-6383
CY2019Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
7533083
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Shell Company
EntityShellCompany
false
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5671000
us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
us-gaap:ProductMember
us-gaap Cost Of Revenue
CostOfRevenue
1920000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1332000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2707000
dei Entity File Number
EntityFileNumber
0-51891
CY2019Q2 us-gaap Cash
Cash
595000
CY2018Q4 us-gaap Cash
Cash
1075000
CY2019Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
976000
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
651000
CY2019Q2 us-gaap Inventory Net
InventoryNet
1317000
CY2018Q4 us-gaap Inventory Net
InventoryNet
1501000
CY2019Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
440000
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
543000
CY2019Q2 us-gaap Assets Current
AssetsCurrent
3328000
CY2018Q4 us-gaap Assets Current
AssetsCurrent
3770000
CY2019Q2 us-gaap Inventory Noncurrent
InventoryNoncurrent
784000
CY2018Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
805000
CY2019Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
697000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
469000
CY2019Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2790000
CY2018Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2674000
CY2019Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
849000
CY2019Q2 isco Deposits And Other Assets
DepositsAndOtherAssets
93000
CY2018Q4 isco Deposits And Other Assets
DepositsAndOtherAssets
78000
CY2019Q2 us-gaap Assets
Assets
8541000
CY2018Q4 us-gaap Assets
Assets
7796000
CY2019Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
731000
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
458000
CY2019Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
548000
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
579000
CY2019Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
265000
CY2019Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
1827000
CY2018Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
2045000
CY2019Q2 isco Advances From Nonaffiliated Collaboration
AdvancesFromNonaffiliatedCollaboration
250000
CY2018Q4 isco Advances From Nonaffiliated Collaboration
AdvancesFromNonaffiliatedCollaboration
250000
CY2019Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
837000
CY2018Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
1745000
CY2019Q2 us-gaap Liabilities Current
LiabilitiesCurrent
4458000
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5077000
CY2018Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
182000
CY2019Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
974000
CY2019Q2 us-gaap Liabilities
Liabilities
5432000
CY2018Q4 us-gaap Liabilities
Liabilities
5259000
CY2019Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
120000000
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
120000000
CY2019Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7533083
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6933861
CY2019Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7533083
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6933861
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2321000
CY2018Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3038000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4539000
CY2019Q2 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
us-gaap:ProductMember
CY2018Q2 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
us-gaap:ProductMember
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-394000
CY2018Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
624000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1263000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1430000
CY2019Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1398000
CY2019Q2 us-gaap Cost Of Revenue
CostOfRevenue
857000
us-gaap Cost Of Revenue
CostOfRevenue
1698000
us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
us-gaap:ProductMember
CY2018Q2 us-gaap Cost Of Revenue
CostOfRevenue
1095000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
2064000
CY2018Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
8000
CY2018Q1 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
90000
CY2018Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
307000
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-830000
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
1639000
CY2018Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
7000
CY2018Q2 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
34000
CY2018Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
357000
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
1643000
CY2019Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
268000
CY2018Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
452000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
921000
CY2019Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
739000
CY2018Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1234000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2920000
CY2019Q2 us-gaap Costs And Expenses
CostsAndExpenses
3262000
CY2018Q2 us-gaap Costs And Expenses
CostsAndExpenses
3405000
us-gaap Costs And Expenses
CostsAndExpenses
6969000
us-gaap Costs And Expenses
CostsAndExpenses
7222000
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-941000
CY2018Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-367000
us-gaap Operating Income Loss
OperatingIncomeLoss
-2430000
us-gaap Operating Income Loss
OperatingIncomeLoss
-1551000
CY2019Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-311000
CY2018Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
21000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-908000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-334000
CY2019Q2 us-gaap Interest Expense
InterestExpense
20000
CY2018Q2 us-gaap Interest Expense
InterestExpense
7000
us-gaap Interest Expense
InterestExpense
34000
us-gaap Interest Expense
InterestExpense
9000
CY2019Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
2000
CY2018Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
1000
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
2000
CY2019Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
293000
CY2018Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-27000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-648000
CY2019Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-648000
CY2018Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-394000
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.09
CY2018Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.09
CY2018Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7533000
CY2018Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6225000
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7533000
CY2018Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6225000
CY2019Q1 isco Adjustments Related To Error Correction In Equity
AdjustmentsRelatedToErrorCorrectionInEquity
-4300000
CY2019Q1 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
1049000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-906000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
-1114000
us-gaap Profit Loss
ProfitLoss
-1554000
us-gaap Profit Loss
ProfitLoss
-1224000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.20
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
2000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
876000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
327000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1554000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1224000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.21
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.20
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.21
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7467000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6181000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7467000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6181000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
506000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
138000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
140000
us-gaap Share Based Compensation
ShareBasedCompensation
1077000
us-gaap Share Based Compensation
ShareBasedCompensation
664000
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
15000
isco Inventory Adjustment
InventoryAdjustment
22000
isco Inventory Adjustment
InventoryAdjustment
32000
us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
30000
us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
8000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-1000
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
204000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
325000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1149000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-184000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
433000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-254000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-212000
us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
16000
us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
-10000
isco Increase Decrease In Right Of Use Assets Under Lease Obligations
IncreaseDecreaseInRightOfUseAssetsUnderLeaseObligations
-158000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
273000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
987000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-66000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
309000
isco Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-150000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-883000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-558000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
113000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
149000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
178000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
247000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-291000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-396000
isco Proceeds From Bridge Loan From Related Party
ProceedsFromBridgeLoanFromRelatedParty
800000
isco Proceeds From Bridge Loan From Related Party
ProceedsFromBridgeLoanFromRelatedParty
1100000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
124000
isco Payments On Financed Insurance Premiums
PaymentsOnFinancedInsurancePremiums
106000
isco Payments On Financed Insurance Premiums
PaymentsOnFinancedInsurancePremiums
97000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
694000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1127000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-480000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
173000
CY2017Q4 us-gaap Cash
Cash
304000
CY2018Q2 us-gaap Cash
Cash
477000
us-gaap Interest Paid Net
InterestPaidNet
3000
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
1049000
us-gaap Supplementary Insurance Information Premiums Written
SupplementaryInsuranceInformationPremiumsWritten
151000
us-gaap Use Of Estimates
UseOfEstimates
<p style="text-align:justify;margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Use of Estimates </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the unaudited condensed consolidated financial statements. Significant estimates include patent life (remaining legal life versus remaining useful life), inventory carrying values, allowance for excess and obsolete inventories, allowance for sales returns and doubtful accounts, and transactions using the Black-Scholes option pricing model, e.g., stock options, as well as the Monte-Carlo valuation method for warrants. Actual results could differ from those estimates. </p>
isco Related Party Rent Expense
RelatedPartyRentExpense
80000
isco Related Party Rent Expense
RelatedPartyRentExpense
80000
CY2019Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2702000
CY2018Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
1745000
CY2019Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
837000
CY2019Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
659000
CY2018Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
656000
CY2019Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
534000
CY2018Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
590000
CY2019Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1146000
CY2018Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1276000
CY2019Q2 us-gaap Inventory Gross
InventoryGross
2339000
CY2018Q4 us-gaap Inventory Gross
InventoryGross
2522000
CY2019Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
238000
CY2018Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
216000
CY2019Q2 isco Inventory Net Current And Noncurrent
InventoryNetCurrentAndNoncurrent
2101000
CY2018Q4 isco Inventory Net Current And Noncurrent
InventoryNetCurrentAndNoncurrent
2306000
CY2019Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3399000
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3121000
isco Maximum Original Maturities Period
MaximumOriginalMaturitiesPeriod
P3M
CY2019Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2018Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2019Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
12000
CY2018Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
12000
CY2008Q2 isco Advances From Nonaffiliated Collaboration
AdvancesFromNonaffiliatedCollaboration
250000
CY2008Q2 isco Specified Amount Of Revenue To Be Utilized First For Advances
SpecifiedAmountOfRevenueToBeUtilizedFirstForAdvances
250000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
0
CY2019Q2 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
204000
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
us-gaap Revenue Performance Obligation Description Of Payment Terms
RevenuePerformanceObligationDescriptionOfPaymentTerms
The Company's revenue consists primarily of sales of products from its two revenue-generating operating segments, the anti-aging cosmetics products and biomedical products business segments. The cosmetic market segment markets and sells a line of luxury skincare products sold through two sales channels: ecommerce and professional. The ecommerce channel sells direct to customers through online orders, while the professional sales are to spas, salons and other skincare providers. The biomedical market segment markets and sells primary human cell research products with two product categories, cells and media, sold both within and outside the United States.
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
isco Product Return Guarantee Period
ProductReturnGuaranteePeriod
P30D
isco Allowance For Sales Return
AllowanceForSalesReturn
0
CY2018 isco Allowance For Sales Return
AllowanceForSalesReturn
0
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2652000
CY2019Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
37000
CY2018Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
44000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
75000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
85000
CY2019Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3810000
CY2018Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3632000
CY2018Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.75
CY2019Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.75
isco Number Of Operating Leases
NumberOfOperatingLeases
3
CY2019Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
1239000
CY2019Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
113000
CY2019Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1020000
CY2018Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
958000
CY2019Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2790000
CY2018Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2674000
CY2019Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
28000
CY2018Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
28000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
62000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
55000
CY2019Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2019Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2019Q1 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
1000000
CY2019Q1 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
49000
isco Convertible Common Stock Conversion Price
ConvertibleCommonStockConversionPrice
1.75
CY2019Q2 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
19531180
CY2019Q2 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
1000000
CY2019Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
800000
CY2019Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
572000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
664000
CY2019Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
3111000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y
CY2018Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
3951052
isco Warrant Forfeited Or Cancelled
WarrantForfeitedOrCancelled
CY2019Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
3951052
us-gaap Operating Lease Cost
OperatingLeaseCost
253000
CY2019Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
118000
us-gaap Operating Lease Payments
OperatingLeasePayments
236000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1389000
CY2019Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y25D
CY2019Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.1746
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
249000
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
368000
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
347000
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
219000
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
226000
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
473000
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1882000
CY2019Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
643000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
491000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
368000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
347000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
220000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
227000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
454000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
2107000
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3
isco Number Of Business Units
NumberOfBusinessUnits
2

Files In Submission

Name View Source Status
0001564590-19-033042-index-headers.html Edgar Link pending
0001564590-19-033042-index.html Edgar Link pending
0001564590-19-033042.txt Edgar Link pending
0001564590-19-033042-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
isco-10q_20190630.htm Edgar Link pending
isco-20190630.xml Edgar Link completed
isco-20190630.xsd Edgar Link pending
isco-20190630_cal.xml Edgar Link unprocessable
isco-20190630_def.xml Edgar Link unprocessable
isco-20190630_lab.xml Edgar Link unprocessable
isco-20190630_pre.xml Edgar Link unprocessable
isco-ex311_6.htm Edgar Link pending
isco-ex312_9.htm Edgar Link pending
isco-ex321_7.htm Edgar Link pending
isco-ex322_8.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending